93 related articles for article (PubMed ID: 25032521)
21. Prognostic implications of depression and inflammation in patients with metastatic lung cancer.
McFarland DC; Saracino RM; Miller AH; Breitbart W; Rosenfeld B; Nelson C
Future Oncol; 2021 Jan; 17(2):183-196. PubMed ID: 33305608
[No Abstract] [Full Text] [Related]
22. Preoperative evaluation of visceral pleural invasion in peripheral lung cancer utilizing deep learning technology.
Kudo Y; Saito A; Horiuchi T; Murakami K; Kobayashi M; Matsubayashi J; Nagao T; Ohira T; Kuroda M; Ikeda N
Surg Today; 2024 May; ():. PubMed ID: 38782767
[TBL] [Abstract][Full Text] [Related]
23. Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.
Yuan P; Cao JL; Rustam A; Zhang C; Yuan XS; Bao FC; Lv W; Hu J
Sci Rep; 2016 Jun; 6():28477. PubMed ID: 27346236
[TBL] [Abstract][Full Text] [Related]
24. A CT-based deep learning model: visceral pleural invasion and survival prediction in clinical stage IA lung adenocarcinoma.
Lin X; Liu K; Li K; Chen X; Chen B; Li S; Chen H; Li L
iScience; 2024 Jan; 27(1):108712. PubMed ID: 38205257
[TBL] [Abstract][Full Text] [Related]
25. Research progress in predicting visceral pleural invasion of lung cancer: a narrative review.
Wang Y; Lyu D; Fan L; Liu S
Transl Cancer Res; 2024 Jan; 13(1):462-470. PubMed ID: 38410233
[TBL] [Abstract][Full Text] [Related]
26. Non-small Cell Lung Cancer Surpassing the Elastic Layer Should Remain Classified as pT2a.
Cai JS; Dou XM
Semin Thorac Cardiovasc Surg; 2023 Autumn; 35(3):583-593. PubMed ID: 35550846
[TBL] [Abstract][Full Text] [Related]
27. Comparison of model-building strategies for excess hazard regression models in the context of cancer epidemiology.
Maringe C; Belot A; Rubio FJ; Rachet B
BMC Med Res Methodol; 2019 Nov; 19(1):210. PubMed ID: 31747928
[TBL] [Abstract][Full Text] [Related]
28. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
[TBL] [Abstract][Full Text] [Related]
29. Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer.
Huang H; Wang T; Hu B; Pan C
Ann Thorac Surg; 2015 Apr; 99(4):1130-9. PubMed ID: 25704861
[TBL] [Abstract][Full Text] [Related]
30. Level of pleural invasion effects on prognosis in lung cancer.
Tanju S; Erus S; Selçukbiricik F; İliaz S; Kapdağlı M; Bulutay P; Sevinç TE; Mandel NM; Dilege Ş
Tumori; 2019 Apr; 105(2):155-160. PubMed ID: 30165792
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
32. Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.
Zhang T; Zhang JT; Li WF; Lin JT; Liu SY; Yan HH; Yang JJ; Yang XN; Wu YL; Nie Q; Zhong WZ
J Thorac Dis; 2019 Jul; 11(7):2754-2762. PubMed ID: 31463103
[TBL] [Abstract][Full Text] [Related]
33. Influence of visceral pleural invasion on survival in completely resected non-small-cell lung cancer.
Adachi H; Tsuboi M; Nishii T; Yamamoto T; Nagashima T; Ando K; Ishikawa Y; Woo T; Watanabe K; Kumakiri Y; Maehara T; Morohoshi T; Nakayama H; Masuda M
Eur J Cardiothorac Surg; 2015 Nov; 48(5):691-7; discussion 697. PubMed ID: 25564209
[TBL] [Abstract][Full Text] [Related]
34. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients.
Okada S; Hattori A; Matsunaga T; Takamochi K; Oh S; Inoue M; Suzuki K
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):303-310. PubMed ID: 32918675
[TBL] [Abstract][Full Text] [Related]
36. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
[TBL] [Abstract][Full Text] [Related]
37. Survival with Parenchymal and Pleural Invasion of Non-Small Cell Lung Cancers Less than 30 mm.
Yip R; Ma T; Flores RM; Yankelevitz D; Henschke CI;
J Thorac Oncol; 2019 May; 14(5):890-902. PubMed ID: 30685507
[TBL] [Abstract][Full Text] [Related]
38. The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures.
Sakakura N; Mizuno T; Kuroda H; Arimura T; Yatabe Y; Yoshimura K; Sakao Y
Lung Cancer; 2018 Apr; 118():134-138. PubMed ID: 29571992
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
40. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
